Application of Aescin‐Loaded Chitosan Nanoparticles for Enhancement of DNA Damage and Associated cGAS Pathway in A549 Lung Cancer Cells
IUBMB Life · 2026-11 · 78 (11)
DOI: 10.1002/iub.70139 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, online erschienen am 09.11.2026. Verfasst von Muthusamy Rajasekar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Research Laboratory for Biomedical Research, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Researc…. Hauptthemen laut MEDLINE: Chitosan, DNA Damage, Nanoparticles, Lung Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, NSYSU-KMU Joint Research Project.
Abstract (Originalsprache)
The cGAS‐STING pathway plays a central role in detecting cytosolic DNA in addition to initiating immune responses against tumor cells. The present study investigates the efficacy of Aescin‐loaded chitosan nanoparticles (AESC‐CSNPs) in enhancing DNA damage and associated cGAS pathway in A549 lung cancer cells. AESC‐CSNPs were synthesized using the ionic gelation method, and characterization was performed to analyze the particle size, surface charge, and encapsulation efficiency. A549 lung cancer cells treated with AESC‐CSNPs displayed augmented levels of DNA damage indications, such as γ‐H2AX, signifying more DNA double‐strand breaks. Western blotting showed higher levels of cGAS, STING, and phosphorylated TBK1, specifying the initiation of the cGAS‐STING cascade. Furthermore, the increase of mainstream cytokines, such as IFN‐β and IL‐6, was confirmed by qRT‐PCR, indicating a pro‐inflammatory response by the immune system. Annexin V/PI discoloration and flow cytometry further displayed that AESC‐CSNPs induced apoptosis in association with DNA damage. These results suggested that AESC‐CSNPs could induce damage in the DNA of A549 lung cancer cells, contributing to an initiation of cGAS, with its associated anti‐tumor response. Thus, this study identifies AESC‐CSNPs as a promising strategy to affect the A549 cells to immune shadowing and apoptosis by the associated cGAS‐STING pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Research Laboratory for Biomedical Research, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (DU), Salem, Tamil Nadu, India.
- Department of Biotechnology, School of Biosciences and Technology, SRM Institute of Science and Technology (SRMIST) Tiruchirappalli Campus, Tiruchirappalli, Tamil Nadu, India.
- Department of Biochemistry and Biotechnology, Annamalai University, Chidambaram, Tamil Nadu, India.
- Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan.
ORCID-Profile: Muthusamy Rajasekar, Shantkriti Srinivasan, Maria Joseph AngelaaLincy, Babu Senthil Kumar, Theerthu Azhamuthu, Kathiresan Suresh, A Santhana Krishna Kumar
Förderung
- National Science and Technology Council
- NSYSU-KMU Joint Research Project
Zitieren
APA
Rajasekar, M., Srinivasan, S., AngelaaLincy, M. J., Kumar, B. S., Azhamuthu, T., Suresh, K., & Kumar, A. S. K. (2026). Application of Aescin‐Loaded Chitosan Nanoparticles for Enhancement of DNA Damage and Associated cGAS Pathway in A549 Lung Cancer Cells. IUBMB Life, 78(11). https://doi.org/10.1002/iub.70139
Vancouver
Rajasekar M, Srinivasan S, AngelaaLincy MJ, Kumar BS, Azhamuthu T, Suresh K, et al. Application of Aescin‐Loaded Chitosan Nanoparticles for Enhancement of DNA Damage and Associated cGAS Pathway in A549 Lung Cancer Cells. IUBMB Life. 2026;78(11). doi:10.1002/iub.70139
BibTeX
@article{Rajasekar2026,
author = {Rajasekar, Muthusamy and Srinivasan, Shantkriti and AngelaaLincy, Maria Joseph and Kumar, Babu Senthil and Azhamuthu, Theerthu and Suresh, Kathiresan and Kumar, A Santhana Krishna},
title = {Application of Aescin‐Loaded Chitosan Nanoparticles for Enhancement of DNA Damage and Associated cGAS Pathway in A549 Lung Cancer Cells},
journal = {IUBMB Life},
year = {2026},
volume = {78},
number = {11},
doi = {10.1002/iub.70139}
}
EUVIMED